Wednesday, 15 Aug 2018

You are here

The RheumNow Week in Review – Lupus in the News (7.27.18)

Dr. Jack Cush reviews the news and journal reports from the past week on

  1. ARD reports 384 Seropositive RA patients from the IMPROVED study were followed; those who become seronegative over the first year of treatment did not have a better chance of drug-free remission
  2. FDA grants orphan drug status to lenabasum (cannabinoid receptor agonist) for dermatomyositis
  3. Pain in DISH is usually not from DISH; Likely another cause/problem. Pts usually asymptomatic but may complain of thoracolumbar or neck stiffness. DISH is a bone-forming diathesis primarily affecting the spine, with ossification of tendons and ligaments.
  4. Limited data on pregnancy outcomes with tofacitinib exposure encouraging. In RA , 47 women, 44 men exposed, w/ 1 congenital defect. In UC studies 11 maternal and 14 paternal exposures w/ no congenital malformations
  5. Cohort of 214 criteria proven antiphospholipid syndrome (APS) pts; after excluding 85 w/ >=1 SLE feature, 8 w/ CTD, 21 w/ ANA>1/320; leaves 100 with primary APS. None developed Lupus after 12 yrs F/U, yet 28% had >3 SLICC criteria
  6. According 2018 Medscape RESIDENTS Salary and debt report, Rheumatology Fellows are 2nd best paid (Allergy/Immunology 1st) making average of $66,200 - better than surgery, GI, critical care. 47% have >$200K med school debt.
  7. Among 147 SLE patients from Denmark, half (74) had lupus nephritis (LN). LN pts with reduced renal function (<70cc/min) were 6 times more likely to have coronary artery calcifications and carotid plaque.
  8. Study of 84 GCA & Takayasu's pts assessed w/ MRA vs PET scans showing complementary info. 60% agreement betw the two in Dz extent; 68% in Dz activity. MRA better captures disease extent, and PET scan is better suited to assess vascular activity..
  9. Lancet: Baricitinib Effective in SLE Trial 
  10. Predicting Autoimmune Progression in ANA+ Patients 
  11. Erectile Dysfunction in Gout  
  12. Consensus Guidelines for Methotrexate in Juvenile Idiopathic Arthritis  
  13. Latin American Clinical Practice Guidelines for Lupus 


The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

U.S. News 2018-19 Rheumatology Rankings

The Annual U.S. News and World Report Rankings of Hospitals has listed the top contenders in the field of rheumatology. The U.S. News Review rates hospitals nationwide in 16 specialties – including rheumatology. Of the 4,500 hospitals covered by U.S. News that were analyzed, 158 were classified nationally in at least one specialty area.

The RheumNow Week in Review – No Good Gout (8.10.18)

Dr. Jack Cush reviews the news and latest journal articles from the past week on Info on Surgery and Hip Fractures, Gout drugs abandoned, Allopurinol escalation, hydroxychloroquine drug levels, how to treat scleroderma in India and exactly who gets back pain.

The RheumNow Week in Review – Handshakes or Hugs (8.3.18)

Dr. Jack Cush reviews the news and highlights from the past week on, including new treatments for LTBI, gout consequences, RA and offspring risk, PsA risk, and the opioid epidemic effects.

The RheumNow Week in Review – Cocoon Therapy? (7.20.18)

Dr. Jack Cush reviews highlights from the news and social media on in the past week. 

Proposed Changes for 2019 Medicare Fee Schedule

On July 12th the Centers for Medicare & Medicaid Services (CMS) released its proposed rule changes for the 2019 Medicare physician fee schedule.  This year, CMS has combined the Medicare physician fee schedule proposed rule with recommendations for the Quality Payment Program (QPP), which will be officially published in the Federal Register on July 27.